Navigation Links
Anadys Pharmaceuticals Commences Dosing ANA773 in Hepatitis C Patients
Date:10/30/2008

transplantation in the United States. Due to the asymptomatic nature of HCV infection, it often goes undetected for up to 20 years following initial infection. Each year, 8,000 to 10,000 people in the United States die from complications of HCV.

The current standard of care is a combination of pegylated interferon and ribavirin. Inadequate response rates, in particular for patients infected with genotype 1 HCV, along with significant side effects of approved therapy support the medical need for improved treatment options. It is estimated that fewer than 5% of people with chronic HCV infection living in the United States are under treatment today. Most infected individuals are unaware of their infection status and the large majority of individuals who know their condition do not currently receive drug therapy. There is also a growing number of individuals who have failed interferon-based regimens who may be successfully treated with combinations of two or more direct antivirals. It is expected that the next generation of therapies for treatment of HCV will include small molecules, such as ANA598, that directly act upon specific viral enzymes to inhibit viral replication and orally administered agents such as ANA773, which are being developed to potentially replace injectable interferon. These new therapies are expected to improve overall therapy by increasing cure rates and potentially improving tolerability and convenience of treatment if doses of currently used agents can be reduced or eliminated.

About Anadys

Anadys Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to improving patient care by developing novel medicines in the areas of hepatitis C and oncology. For the treatment of chronic hepatitis C, the Company is developing two potentially complementary agents: ANA598, a non-nucleoside polymerase inhibitor and ANA773, an oral TLR7 agonist prodrug. The Company is also developing ANA773 for the treatment of cance
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
2. Anadys Pharmaceuticals to Report Third Quarter 2007 Financial Results
3. Anadys Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw Healthcare Conference
4. Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
5. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
6. Anadys Pharmaceuticals to Present at the JPMorgan Healthcare Conference
7. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
8. Anadys Pharmaceuticals to Report Fourth Quarter and Year-End 2007 Financial Results
9. Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant Options in Healthcare Conference
10. Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients
11. Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... NY (PRWEB) August 01, 2014 ... a provider of DNA-based anti-counterfeiting technology and product authentication ... 12, 2014 to discuss its fiscal third quarter results. ... with the SEC by the end of the day ... Sciences, Inc. management will host a conference call beginning ...
(Date:8/1/2014)... 2014 This is a professional and ... Bicarbonate industry in Global and China. The report provides ... and industry chain structure. Global market analysis and Chinese ... history, developments, trends and competitive landscape of the market. ... also offered. , The report also focuses on development ...
(Date:8/1/2014)... -- Research and Markets  has announced the ... Flow Cytometry in IVD Applications" report to ... Flow cytometers are powerful reference ... of advanced IVD labs in developed nations. They ... their newer clinical applications included the commercialization and ...
(Date:8/1/2014)... 01, 2014 RURO, Inc., Laboratory ... today officially announces the opening of its first ... Park, Baoshan District in Shanghai, PRC, RURO Shanghai’s ... the management of Mr. Shen Gang, the former ... past three years, RURO’s has installed FreezerPro-based solutions ...
Breaking Biology Technology:Applied DNA Sciences to Host Conference Call Tuesday August 12, 2014 2Applied DNA Sciences to Host Conference Call Tuesday August 12, 2014 3Ammonium Bicarbonate Market in Internations & Chinese Regions Research Analysis Now Available at DeepResearchReports.com 2Ammonium Bicarbonate Market in Internations & Chinese Regions Research Analysis Now Available at DeepResearchReports.com 3The World Market for Flow Cytometry in IVD Applications 2RURO Opens Office in Shanghai, China 2
... Inc. (NASDAQ: DSCO ), a specialty biotechnology ... critical care, reported that data from a preclinical study ... recently published in the May issue of Pediatric ... improvements in lung function following administration of SURFAXIN LS ...
... Fluke Biomedical announced today their popular ... a global audience with the addition of ... http://photos.prnewswire.com/prnh/20120509/SF03362 ) (Logo: http://photos.prnewswire.com/prnh/20120130/SF43337LOGO-b ... the Fluke Biomedical Advantage training center quickly ...
... Biotech Group, a global genomic products and service ... testing for a proprietary targeted chromosomal microarray (CMA) ... microdeletions and microduplications related to a spectrum of ... Cyto OneArray ® is capable of ...
Cached Biology Technology:Newly-Published Study Compares SURFAXIN LS™ and CUROSURF® in Well-Established Model of Respiratory Distress Syndrome 2Newly-Published Study Compares SURFAXIN LS™ and CUROSURF® in Well-Established Model of Respiratory Distress Syndrome 3Newly-Published Study Compares SURFAXIN LS™ and CUROSURF® in Well-Established Model of Respiratory Distress Syndrome 4Newly-Published Study Compares SURFAXIN LS™ and CUROSURF® in Well-Established Model of Respiratory Distress Syndrome 5Fluke Biomedical training center goes global: adds multi-language support 2Phalanx Biotech Group Announces CytoOneArray®, a Targeted Chromosomal Microarray 2
(Date:8/1/2014)... and transgender individuals who want to conceive a child ... heterosexual and cisgendered peers, such as reduced fertility, but ... legal challenges to become parents. A comprehensive review of ... presented in the article " LGBT Assisted Reproduction: Current ... LGBT Health , a peer-reviewed journal from Mary ...
(Date:8/1/2014)... of marine mammals have officially named a species ... Sousa sahulensis , according to the Wildlife Conservation ... describing the newly named species is the culmination ... available historical records, physical descriptions, and genetic data ... ranging from the coast of West Africa to ...
(Date:8/1/2014)... Understanding eye diseases is tricky enough. Knowing what causes ... , Now, University of Iowa researchers have created the ... the human eye long associated with blinding diseases, such ... thousands of proteins in the choroid, which supplies blood ... vision. By seeing differences in the abundance of proteins ...
Breaking Biology News(10 mins):Advances in assisted reproduction create more options & new legal issues for LGBT couples 2Scientists name new species of cetacean: The Australian humpback dolphin 2Scientists name new species of cetacean: The Australian humpback dolphin 3A map for eye disease 2
... been debated in philosophical circles, and more recently, evolutionary ... of natural selection, altruism may have evolved because any ... and reproduction increases the chance of an individual,s DNA ... altruism are well known in the animal kingdom; however, ...
... -- Amphibians, for years considered a leading indicator of ... to a meta-analysis to be published in Ecology ... toxicological tests, researchers from the University of South Dakota, ... prevailing view that amphibians, with their permeable skin and ...
... international group of researchers from Carnegie Mellon University, Goettingen ... in the United Kingdom have received a Human Frontiers ... will help researchers better understand the "cellular GPS" system ... system. In the course of the development ...
Cached Biology News:Can a plant be altruistic? 2Amphibians as environmental omen disputed 2Carnegie Mellon researchers to develop probes to study cellular GPS 2
... a dedicated system for SFC and SFE ... of HPLC instrumentation. JASCO has recently added ... of the system: ,- The PU-1580-CO2 delivery ... procedures using carbon dioxide as the mobile ...
...
... Fixed clamp trays and ... Magnetic drive ... 25 mm amplitude ... ml to 2000 ml, including Fernbach ...
... generation of microarrays to detect alternative splicing. ... rapidly elucidate alternatively spliced events in gene ... discovery. The service combines ExonHits proprietary splice ... analysis with Agilents robust microarray platform. The ...
Biology Products: